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The recently proposed Research Domain Criteria (RDoC) system deﬁnes psychopathologies as phe-
nomena of multilevel neurobiological existence and assigns them to 5 behavioural domains character-
izing a brain in action. We performed an analysis on this contemporary concept of psychopathologies in
respect to a brain phylogeny and biological substrates of psychiatric diseases. We found that the RDoC
system uses biological determinism to explain the pathogenesis of distinct psychiatric symptoms and
emphasises exploration of endophenotypes but not of complex diseases. Therefore, as a possible
framework for experimental studies it allows one to evade a major challenge of translational studies of
strict disease-to-model correspondence. The system conforms with the concept of a normality and pa-
thology continuum, therefore, supports basic studies. The units of analysis of the RDoC system appear as
a novel matrix for model validation. The general regulation and arousal, positive valence, negative
valence, and social interactions behavioural domains of the RDoC system show basic construct, network,
and phenomenological homologies between human and experimental animals. The nature and
complexity of the cognitive behavioural domain of the RDoC system deserve further clariﬁcation. These
homologies in the 4 domains justiﬁes the validity, reliably and translatability of animal models appearing
as endophenotypes of the negative and positive affect, social interaction and general regulation and
arousal systems’ dysfunction.
© 2017 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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E. Anderzhanova et al. / Neurobiology of Stress 7 (2017) 47e56481. Nosological entity problem in psychiatry 2. Evolutional and neurobiological understanding ofA fundamental problem of clinical diagnosis in psychiatry is the
identiﬁcation of disease as an objective and unique entity. Emil
Kraepelin established the basis for modern nosology of psychiatric
diseases (Kraepelin, 1893, 1896). The contemporary International
Statistical Classiﬁcation of Diseases and Related Health Problems
(ICD-10, 1989, http://www.who.int/classiﬁcations/icd/en/) and the
Diagnostics and Statistics Manual of Mental Disorders (DSM-5,
2013, http://www.dsm5.org/Pages/Default.aspx) imply a clear
distinction of nosological entities from normality and from each
other. Diagnosis of psychopathologies is mostly based on the
presence of deviant behaviour, self-evaluated discontent, behav-
ioural maladaptation and danger posed to the patient or others. The
categorical assignment of illnesses is justiﬁed by practical needs,
such as uniﬁcation of data across medical institutions, statistics, on
default diagnostic efforts and treatment and on ofﬁcial grounds of
reimbursement for a diagnostic means and therapeutic in-
terventions by health insurance companies. However, diagnostic
complexity and the lack of conﬁdence in the ﬁnal diagnosis often
result in a formal use of contemporary nosological classiﬁcations
(Maj, 2015).
Nosological entities imply the existence of speciﬁc causations.
As a result, major efforts have been made to try to identify speciﬁc
hallmarks of pathogenesis or associated genes using objective
measurements in order to gain a high level of diagnostic reliability.
Despite this effort, no clear markers have been identiﬁed that are
indicative for existing psychiatric nosological entities. On a
morphological level, volume reduction of cortical areas and the
hippocampal formation has been reported for major depression
and schizophrenia (Bremner et al., 2000; Meisenzahl et al., 2010;
Nelson et al., 1998). Complex changes in molecular factors such as
receptors expression, transporters and secondary messengers
(Nikolaus et al., 2012; Scarr et al., 2015) contribute to a deteriora-
tion in neuroplasticity and synaptogenesis and are seen throughout
the brain without clear nosological distinction (Bernardinelli et al.,
2014; Kassem et al., 2013). Speciﬁcity of genetic signatures will only
be possible with a tremendous increase in sample size, which will
correspond ironically to lower nosological precision (Hyde et al.,
2016; Ripke et al., 2014).
The failure to identify speciﬁc markers can be explained as fol-
lows: (1) A linear and ﬁnite relationship between the cause and
outcome is a rare in psychiatric disease (Fig. 1, left). Instead, there
are many reciprocal interactions between the biological back-
ground, its functional expression and numerous exogenous factors
(Fig. 1, right). (2) The theory of allostatic load introduces preceding
experience as a factor that may recalibrate the behavioural and
physiological reactions and change the adaptation potential (Ellis
and Del Giudice, 2014; McEwen, 1998; Nederhof and Schmidt,
2012). Environmental stress is considered as a pathogenetic
element of a high importance in psychiatry (De Kloet et al., 2005;
McEwen and Stellar, 1993; McEwen, 2008; Millan et al., 2012;
Peyrot et al., 2015). (3) The interaction between the genome and
the environment has a strong context limiting/permitting compo-
nent (Notaras et al., 2016). Mechanisms that evolved over millions
of years to protect individuals from a life-threatening environment
have become maladaptive in respect to contemporary socio-
cultural demands (Del Giudice, 2016; Ellis and Del Giudice, 2014;
First and Wakeﬁeld, 2013). (4) This research approach is problem-
atic as it keeps the nosological entity as the focus. Jaspers (1913)
insisted that a nosological entity is a goal for study, but not an
objectively existing phenomenon. Thus, any nosological approach
to stratify disease should be viewed as a diagnostic strategy rather
than approach to research distinct pathogenesis.psychopathology
MacLean (1970, 1985, and 1990) ﬁrst recognized the importance
of an evolutionary concept to understand the regulation of mental
function and proposed The Triune Brain Model (Fig. 2, left). Ac-
cording to MacLean, the phylogenetically oldest Protoreptilian brain
provides instinctive actions, which are the basis of essential be-
haviours necessary for survival (e.g., exploration, escape behaviour,
foraging, feeding, aggression, domination and reproductive
behaviour). The Paleomammalian formation comprises parts of the
brain that are conventionally assigned to the limbic system (or
Papez circuit, Papez, 1937). It is responsible for emotions and
motivation and transforms a primary response to more adaptive
ones, based on previous experience and instincts. The neocortical
Neomammalian formation provides actual declarative knowledge of
all incoming sensory information.
The Triune Brain Model was followed by The Affective Neuro-
science Scale system (Davis and Panksepp, 2011; Panksepp, 1998,
2005). According to Panksepp's theory, core emotional affects and
defensive behaviours are represented by the diencephalic action
systems of “Panic”, “Fear”, Rage”, “Lust”, “Seeking”, Care” and “Play”
(Fig. 2, middle). Genetically determined neuronal networks are
considered as neurobiological substrates of these behaviours
(Panksepp, 1998) and appear to be conserved throughout the
mammalian evolution (Berridge, 2000; Saudino, 2005; Rutter et al.,
1997). Emotions and defence behaviours serve focused and
distinguished behavioural goals, and, therefore, can be controlled
with speciﬁc stimuli and operate relatively independently (e.g.,
Anderson and Adolphs, 2014). Three reference points were sug-
gested to specify the network, responsible for 1 of the behaviour
characteristics selected by Pankseep: (1) similar neuronal circuits
maintain coherent functions; (2) artiﬁcial stimulation of the
particular network (with a pharmacological, electrophysiological,
and opto-/chemo-genetic means) generates predicted responses;
and (3) changes in the carriers of the network activity (neuro-
transmitters and other substances with messenger activity) predict
the behavioural changes (Panksepp, 1998). A lot of research aims to
decipher the circuitries that predominantly control (1) arousal and
sleep (Herrera et al., 2016; Kim et al., 2012; Landgraf et al., 2016), (2)
fear, (3) anxiety, (4) aversive memories (Bravo-Rivera et al., 2014;
Kim et al., 2013; McCullough et al., 2016; Tovote et al., 2015), (5)
reward (Kelley, 2004; Kelley and Berridge, 2002; Smith et al., 2011),
(6) attention and motivation (Berthet et al., 2016; Carli and
Invernizzi, 2014; Kim, 2013), (7) goal-oriented behaviour and
habits (Burguiere et al., 2015; Chersi et al., 2013; Frank, 2011;
Gremel and Costa, 2013; Medendorp et al., 2011) and (8) social
functions (Konopka and Roberts, 2016; Kragel et al., 2015; Sladky
et al., 2015; Zikopoulos and Barbas, 2013).
The objective partition of the networks is nonetheless neither a
physical nor functional segregation. Thus, emotional affect net-
works are integrated into the limbic system of the brain. In turn, the
emotional homeostasis provided by the limbic system deﬁnes the
efﬁcacy of both the phylogenetically old defence systems and more
advanced cognitive functions (deWaal, 2011; Panksepp, 2005; Park
et al., 2016; Vermunt et al., 2016). In turn, the reﬁned cortical
functions favour better top-down control over the affective be-
haviours and provide more efﬁcient adaptation strategies (Adhikari
et al., 2015; Comte et al., 2016; Parikh et al., 2016; Rajasethupathy
et al., 2015). For instance, recent fMRI ﬁndings on activity in the
prefrontal cortex and anterior/posterior cingulate cortex have
shown that these cortical structures exert inhibitory top-down
control of emotional responses. This results in suppression of the
context-irrelevant behavioural activity (Fair et al., 2008; Jaffard
Fig. 1. The bottom-up and top-down model approach in experimental biology. The genotype-outcome interaction implies a dynamic functional network (right), which com-
prises the bottom-up and top-down directions, the most commonly used approaches to model pathological states (left).
Fig. 2. How The Triune brain and The Affective Neuroscience Scale corresponds to the RDoC system. According to the RDoC system, behavioural endophenotypes attribute 5
main behavioural domains. They are not only distinct but describe personality as an interacting and dynamic individual trait. The domains are objectively different, determined by
particular neuronal networks. Separation of the networks is due to a distinction in the functions they serve (The Affective Neuroscience Scale, Panksepp, 1998). This distinction
corresponds well with the concept of a gradual evolution of the brain (the triune brain model of MacLean, 1970).
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tween cognitive, emotional and defensive functions is well recog-
nized, the principles and exact mechanisms of their integration are
only just starting to be explored (Do-Monte et al., 2015; Fan et al.,
2015; Riga et al., 2014; Robinson et al., 2014).
Cognitive-emotional imbalance, as reﬂected by disturbances in
the functional crosstalk between the cortex and limbic/defence
systems, is seen as the basis of psychiatric diseases as well as
psychiatric symptoms in neurodegenerative disorders (reviewed in
Ploog, 2003). The pathology-associated alteration in brain activity
can be visualised by functional imaging studies. For example, fMRI
has revealed that generalised anxiety coincides with stable char-
acteristic changes in functional connectivity (Makovac et al., 2016;
Mohlman et al., 2015; also, Lang et al., 2000).3. The RDoC system as a new framework for categorizing
psychopathologies
The Research Domains Criteria (RDoC, http://www.nimh.nih.
gov/research-priorities/rdoc/index) framework was introduced by
NIMH experts as an alternative categorization system for psycho-
pathological states (Cuthbert, 2014; Cuthbert and Insel, 2010; Insel
et al., 2010). At present, 5 behavioural domains form the basis of the
classiﬁcation matrix: (1) positive valence systems, (2) negative
valence systems, (3) arousal/regulation systems, (4) systems for
social processes and (5) cognitive systems. These 5 domains and
their respective constructs (Fig. 2, right) can be used to compre-
hensively proﬁle behaviour (http://www.nimh.nih.gov/research-
priorities/rdoc/rdoc-constructs). The novelty of the RDoC system
is that changes at all neurobiological levels, from molecules to
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cording to the webpage, the proposed units of analysis are: genes,
molecules, cells, circuits, physiology, behaviour, self-reports and
paradigms. The development of the RDoC diagnostic criteria was
supported by the concept of neuronal networks underlying basic
behavioural domains and promoted by advances in functional
diagnosis and imaging.
The European Roadmap for Mental Health Research project
(ROAMER) aimed to stratify diagnosis, monitoring and treatment of
psychiatric disorder. It resulted in the formulation of a similar
domain structure (http://www.roamer-mh.org/). The pharmaco-
logical treatment cluster and the psychiatric somatic comorbidity
cluster were introduced in addition to the domains already
included in the RDoC (Schumann et al., 2014).
The authors of the RDoC system state: “There is no claim to
“understand” or “explain” DSM/ICD disorders in terms of these (do-
mains and subdomains) functions; rather, the aim is more simply to
seek an understanding of how these various systems may become
dysregulated to various extents and to relate such dysregulation to
relevant symptoms.”
The RDoC system has several advantages as a framework for
guiding preclinical studies: (1) The RDoC supports endophenotype
(symptom)-oriented studies of psychiatric disorders. (2) The
behavioural domain principles do not put a strict demarcation line
between normality and pathology. The RDoC system offers a bio-
logical basis for personality traits complementing The Five-Factor
Model of personality (Costa and McCrae, 1992 Tupes and Christal,
1961; also Davis and Panksepp, 2011; Neuman, 2014). Since psy-
chopathology is considered as a margin case of personality type
(Routtenberg, 2002), the RDoC framework implies a normality-
pathology continuum. This justiﬁes the search for neurobiological
correlates of pathology on a basis of conceptual ﬁndings in normal/
healthy subjects (Karalunas et al., 2014). (4) At a systemic level,
behavioural domains appear to be self-consistent complexes.
Therefore, each domain may represent a leading pathogenic risk
factor. For example, major depression, as a nosological entity,
would be seen not only as result of emotion and mood dysregula-
tion (i.e., changes in the negative valence system), but also as a
failure in the social interactions and positive valence systems with
respective re-set of target for pharmacological interventions. As a
consequence, pharmacological modulation of the oxytocin system
for depression treatment can be better understood in the
perspective of its role in social interaction (Slattery and Neumann,
2010). (5) The same symptoms are present in majority of psychi-
atric disorders. The appearance, for instance, of a depressive state
across a variety of psychiatric diseases supports the idea that all
known nosological entities comprise a continuous spectrum.
Respectively, the comorbidity seen between major depression and
schizophrenia (Samsom and Wong, 2015), bipolar disorder, atten-
tion deﬁcit hyperactivity disorder and autism (Kiser et al., 2015)
imply that the same pathophysiological processes occur. Emer-
gence of common genetic risk factors for these diseases is in line
with such a scenario (Smoller et al., 2013). Therefore, a symptom (or
a drug response) instead of a deﬁned psychiatric diseasemay be the
stratifying principle for genetic studies (Gade et al., 2015; Manchia
et al., 2013; Ohi et al., 2015; Papassotiropoulos and de Quervain,
2015).
However, despite its clear advantages, the RDoC system also
bears a few shortcomings: (1) The RDoC system does not explicitly
take into consideration the developmental and dynamical aspect of
psychiatric disease, but only acknowledges their importance
(Owen, 2014). (2) It does not consider polarity of parameters, either
bipolar (e.g., locomotor activity) or unipolar (e.g., anxiety)
(Papassotiropoulos and de Quervain, 2015). (3) The RDoC system
does not address the fact that gains and losses of function may bedetermined by different mechanisms. For instance, direct and in-
direct pathways of basal ganglia circuit exert biphasic effect in
controlling locomotor activity (Gerfen et al., 1990; Oldenburg and
Sabatini, 2015). (4) Accordingly to phenomenological aspect of
disease, a psychopathological state might be appropriately evalu-
ated only in a context of subject-object and subject-subject in-
teractions. As suggested by Nigg (2015), the RDoC framework does
not consider the developmental or psychosocial context of psy-
chopathological signs, therefore, failing to assign a symptom to
pathology. (5) RDoC implies that all units of analysis, from genes
and molecules to behaviour and paradigms, have the same speciﬁc
stratiﬁcation power. However, no correlation between diagnostic
values of parameters belonging to different units of analysis may be
observed. At the same time, such congruence may be the only
bedrock of units’ supervenience and a basis to explore their inter-
relation. Finally, (6) the RDoC system does not intend to understand
and explore a hierarchy and rules of interaction between behav-
ioural domains.
4. Neurobiological coordinates for experimental phenotypes
and the RDoC system
4.1. Requirements for experimental models of psychopathological
states
The deterministic principle in biology represents a powerful
way to understand the biological processes that shape both
normality and abnormality. In psychiatry, this principle goes back
to Griesenger (1984) who put forward the brain as a substrate of
psychiatric illnesses. Today, psychiatric disorders are seen as a
result of an interaction between intrinsic and environmental fac-
tors. Therefore, a model system should be conceived as a combi-
nation of the experimental subject and applied test situation.
Today we acknowledge the probabilistic aspects of disease that
require a combination of biological and ecological approaches to
model pathology. This renders models powerful in terms of un-
derstanding epigenetic mechanisms of psychopathologies and
prerequisites of resilience vs. susceptibility to disease. This also
claims formore complex and labour-intensivemodels. For instance,
social interaction behaviour can now be observed 24 h a day
using « PhenoWorld» (Castelhano-Carlos et al., 2014; Hong et al.,
2015; Shemesh et al., 2013). Accurate assessment of cognitive
function requires a touch screen approach, which is time
consuming and apparatus-demanding (Romberg et al., 2013).
Contemporary understanding the difference between mechanisms
of sustained fear (anxiety) and phasic fear need sophisticated
protocols with versatile time and context parameters of condi-
tioning (Daldrup et al., 2015; Grillon and Davis, 1997; Seidenbecher
et al., 2016).” The following validity criteria are used to judge the
quality of the disease model: correspondence to the clinical
appearance of disease (face validity); similarity of the morpho-
physiological features of disease (construct validity); predicted
response to pharmacological interventions, speciﬁcally active in
given pathological conditions (predictive validity) (Belzung and
Lemoine, 2011; McKinney and Bunney, 1969; Vervliet and Raes,
2013; Willner, 1984, 1994). Full adherence to these 3 phenotypic
validity criteria is rarely achievable in commonly used experi-
mental animals, such as mice and rats. First of all, tests conﬁrming
face validity and respective proxy measures are not always species
relevant. Thus, the same responses (fear, disgust, afﬁliation, or
pleasure) may have different expression because they drive
species-speciﬁc activity (Cosmides and Tooby, 2000; Flack and de
Waal, 2007). Second, most models bear a limited number of char-
acteristic pathological traits and rarely show typical comorbid
traits, which are co-inherited in human disease. Third, models do
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Forth, the main drawback of experimental models is that they
rarely meet the etiological validity criterion, which includes both
the ontopathogenesis and species homology (Belzung and
Lemoine, 2011). Therefore, speciﬁc animals, perceived as models
of disease, fail to reveal risk factors, prognostic markers and new
therapeutic targets. These problems characterize the crisis of
experimental studies in animals (Ahmed, 2010; Stewart and
Kalueff, 2015; Willner and Belzung, 2015).
The RDoC system is a platform that aims to improve trans-
latability of studies from animals to humans, since it supports the
endophenotype-based comparison of animals and humans on an
objective neurobiological basis across all behavioural domains. The
idea of using observable and objectively measured behaviour to
create animal models of pathology had already been introduced
(Geyer and Moghaddam, 2002; Segal and Geyer, 1985). The RDoC
system advanced to allow the models to be systematized and
grouped, which makes the behavioural endophenotype the pri-
mary focus. The RDoC system offers a useful validation matrix,
where the units of analysis serve as criteria and, together with the
domains, it may be feasible to delineate the areas of homologies
between animal and humans. The RDoc system provides a con-
ceptual approach to study of abnormal endophenotypes consid-
ering them as a deviation of normality. Therefore, it strongly
supports basic/disease focused studies (Bertuzzi and Cleveland,
2015) and justiﬁes using experimental animals to better under-
stand pathological processes.
4.2. Fitting The Affective Neuroscience Scale
We assume that the most reliable comparison between animals
and humans can be done within the 4 RDoC domains, which
describe basic emotions and defence responses. These domains
fully overlap with The Affective Neuroscience Scale (Fig. 2). For
instance, the negative valence systems domain includes the “Fear”
and “Panic” systems. The positive valence systems domain, in turn,
includes the systems responsible for feelings of pleasure and
attachment (“Play”, “Care”, “Lust”, and “Seeking”). The arousal and
regulatory systems combines “Play”, “Seeking”, and “Rage” clusters.
The social processes domain can be deﬁned as a constellation of the
“Play” and “Care”. The anthropocentric names given to emotions,
arousal and defence responses should be used with precaution in
animals, since they are rather nominal or provisional terms. Using
these behavioural emotions with respect to their signiﬁcance to the
entire brain and body would be more representative of their
respective functions (see a review of emotion deﬁnition in deWaal,
20; also, LeDoux, 2014). To prove behavioural and physiological
homologies of emotions and defence programs between species,
we should be assured that even if they do not share similar im-
mediate expression, they may still induce the same changes or
speciﬁcally modify evoked responses to (any) other stimuli.
Together with the phenomenological and neuronal networks’ ho-
mologies, a similarity between humans and animals in physiolog-
ical mechanisms as well as in common genetic and developmental
phenomena of the affective systems (Anderson and Adolphs, 2014;
Heilbronner et al., 2016; Mishra and Gazzaley, 2016) support val-
idity and reliability of the experimental models of dysfunction in
the emotional, regulatory and defence responses.
4.3. Concerning the cognitive systems domain
The ﬁfth domain of the RDoC system, the cognitive system is the
loose accumulation of a variety of cognitive functions (i.e.,
perception, attention, declarative memory, language, working
memory, cognitive control; https://www.nimh.nih.gov/research-priorities/rdoc/constructs/cognitive-systems.shtml). Although the
phylogenetic, physiological and clinical data testify a role of the
cortical structures in the implementation of cognitive functions
(reviewed in Geschwind and Rakic, 2013), so far, neither an
exclusive area of the cortex nor a key network were conﬁrmed to be
a primary bearer or centre of cognition.
As a “system”, the cognitive systems domain emerges as an epi-
formation including all components of the affective systems plus
neocortex and paleocortex. The functional connectivity concept
(Friston, 2011) spans neurobiological and (meta)system approaches
and implies integration of all brain regions in maintaining cognitive
performance. At least in preclinical studies using animal models, it
appears to be impossible to separate the cognitive systems domain
from other behavioural domains (Cromwell and Panksepp, 2011).
The lack of speciﬁc responses serves as indirect evidence that the
cognitive system has no speciﬁc morphological and neurobiological
representation. Thus, cognition cannot be selectively modulated
and pharmacological intervention is often accompanied by changes
in other behavioural domains. Cognitive abilities can be accelerated
coincidentally with improved attention and vigilance in attention
deﬁcit hyperactivity disorder, ADHD (Briars and Todd, 2016; Chan
et al., 2016) or suppression of negative symptoms in major
depression (Al-Sukhni et al., 2015; Baune and Renger, 2014) or
schizophrenia (Goff et al., 2008).
Primary failure in cognitive control may impact emotion pro-
cessing and represents a major factor of psychopathology for
schizophrenia and anxiety disorders (for instance, Mochcovitch
et al., 2014; McTeague et al., 2016). In turn, in depression, deteri-
oration in the emotional domains can lead to cognitive distur-
bances (Darcet et al., 2016; Kim et al., 2016; Porter et al., 2015). For
example, dysfunction in working memory and cognitive ﬂexibility
are observed without relation to actual mood state, but are most
pronounced during episodes of acute mood disturbance (Snyder
et al., 2015).
A complex motivation phenomenon is another example of a
crosstalk between arousal/emotional state and cognitive/learning
performance. Motivation is perceived as a cognitive function in
humans, but at the same time it relates to the positive valence or
negative valence systems. The midbrain reward system, in partic-
ular, the dopaminergic system, signiﬁcantly contributes to “calcu-
lation” of reward values in relation to effort and predicted outcome
(Cools et al., 2009; Saddoris et al., 2015; Schultz and Dickinson,
2000). Therefore, speciﬁc pharmacological interventions effective
in monoaminergic systems (Berridge and Arnsten, 2013;
Westbrook and Braver, 2016) may be a way to study and modu-
late cognitive function.
Themultidomain assignment might be particularly promising if,
for instance, the positive and negative valences are considered as
both function and argument of the cognitive system. For instance,
effective stress coping is a cognitive system-controlled transition
from negative affect to positive affect (Fig. 3). In general, the
objective difference between the complexity of interactions in the
cognitive and affective systems in small experimental animals and
humans provide strong limitations for modelling and studying
cognitive disturbances in mice and rats.
4.4. Putting animal and human behavioural endophenotypes in a
right perspective
Difﬁculties, which appear when matching animal and human
behavioural traits and responses (Nestler and Hyman, 2010), might
be resolved in the following ways:
1. A model should be perceived as an endophenotype/
symptom-based model and considered only as biological
E. Anderzhanova et al. / Neurobiology of Stress 7 (2017) 47e5652system representing a distinct pathological process, but not a
nosological entity.
2. A pathological process must be deﬁned in respect to a
particular concept of pathogenesis of psychopathologies. For
instance, it might be seen as an imbalance between cortical
and subcortical structures or as a state of wrong employment
of a generally adaptive process. This will deﬁne the inter-
pretation and limit possible misinterpretations acquired due
to a deductive analysis (Poldrack, 2006).
3.1 Experimental paradigms, which can be used in both animal
and human studies and, presumably, deal with the same
endophenotypes and readouts, should be ﬁrst choice (Fonio
et al., 2012; Hvoslef-Eide et al., 2015).
3.2 Behavioural tests require validation in respect to their face,
predictive and construct validities in the given context. Thus,
the open ﬁeld test employed to examine locomotor activity
may be a useful tool to discriminate normal adaptive and
pathological anxiety (Prut and Belzung, 2003). Novelty-
induced grooming is regarded as an example of coordi-
nated activity rather than a pathological endophenotype
(Komorowska and Pellis, 2004; Kalueff et al., 2016). Contin-
uous swimming during the forced swim test has an adaptive
value if escape is made possible. If not, lasting efforts lead to
physical exhaustion, which would increase the probability of
negative outcome. The mobility/activity, which can be
measured at earlier phases of the forced swim test, may
correspond to arousal and high vigilance, whereas the
immobility in the later stage may reﬂect behavioural ﬂexi-
bility (Costa et al., 2013; De Pablo et al., 1989; Molendijk and
de Kloet, 2015). Once the meaningfulness of behavioural
parameters is validated, a contextual and/or direct analogy
between signiﬁcance of animal and human behavioural traits
will indicate the human task equivalent (Czeh et al., 2016).
3.3 Evaluation of behavioural responses might be biased due to
experimenter's anthropocentrism. For example, a high level
of aggression, which would serve as an indicator of pathol-
ogy in humans (e.g., during acute alcohol intoxication or due
to degeneration of cortical structures) plays an adaptive role
in mice and is not necessarily accompanied by the develop-
ment of comorbidities like vulnerability to stress and the
development of cardiovascular complications (Brain, 1980;
Brain et al., 1993).
3.4. Underestimation of the species-speciﬁc social interactions
and environmental cues results in artiﬁcial conditions of
housing and grouping patterns of animals, like single-
housing (Arndt et al., 2009; Bartolomucci et al., 2003;
J€ahkel et al., 2000; van Goethem et al., 2012). Careful anal-
ysis and optimization of this and other factors are objective
requirements for contemporary experimental designs. Con-
ditions including limited sized lodging, a pathogen-free
environment, artiﬁcial foraging, limited social and sexual
interactions should be carefully considered but not as
possible confounding factors, rather as ecological de-
terminants of experimental studies (e.g., Beura et al., 2016).
We should use these variables as a source of biological
variability of measured parameters (Voelkl and Würbel,
2016).
3.5. Considering the apparent polymodal character of the do-
mains and context-dependent expression of biomarkers, we
have to acknowledge that any behavioural task or biomedical
measurement can be done appropriately but only on a rela-
tive scale. Therefore, an assessment of experimental endo-
phenotypes should be “calibrated” by coupling genetic
models (e.g., inbred lines) with the predicted difference in a
particular behavioural domain. This is a conceivable way tobetter standardize and validate experiments. For instance,
C57Bl/6 mice show a higher reactivity but a stronger resis-
tance to acute stress than DBA/2 or BALB/c mice (Broadhurst,
1976; Francis et al., 2003; Ibarguen-Vargas et al., 2008). In
any test, relevant to assessment of the same domain, we
should expect a similar relative difference between reference
lines.
4. It should be mandatory to assess the pharmacological re-
sponses to prototypic drugs across all behavioural domains.
This would protect amodel from possiblemisinterpretations.
For example, in our recent studies, we characterized the
inbred low trait anxiety behaviour (LAB) mice as a model of a
psychotic-like continuum (Yen et al., 2013, 2015). In these
LAB mice, we observed endophenotypes that may corre-
spond to the attention deﬁcit hyperactivity disorder, manic
psychosis and schizophrenia. However, since amphetamine
decreases locomotor activity in these mice, they may be an
ADHDmodel and represent an endophenotype that relates to
dysfunction in the regulation/arousal systems domain.4.5. Matching of pathological symptoms and experimental
endophenotypes
Based on the RDoC, the following principles can be applied to
better model pathology in animals:
 Assume a model is an endophenotype model (symptom-based);
 Assign the experimental endophenotype to 1 of the 5 RDoC
domains;
 Identify corresponding symptoms in humans in the same
domain;
 Reveal a spectrum of related clinical symptoms preferentially
within a single syndrome;
 Examine whether developmental, dynamic and co-morbidity
features of the experimental endophenotype ﬁt to the partic-
ular syndrome corresponding to a nosological entity.
 Since disturbance in the cognitive system is a characteristic
feature of psychopathology, evaluation of cognitive function (in
terms of modality and intensity of changes) should be an ulti-
mate step in proposing the phenotype as a psychiatric disease
model.
5. Conclusions
The recently proposed RDoC diagnostic framework is a new
strategy of symptom-based classiﬁcation. It revives and upgrades
the idea of characterizing the basic function of brain rather than the
typical pathological traits (Schneider, 1959). The RDoC system ex-
ploits objective measurements at all levels of neurobiological
investigation from molecules to circuits and behaviour and offers a
biological basis of diagnosis.
At present, the proposed system is still mechanistic and its
nosology-dissecting and aetiology-ﬁnding abilities are a matter of
debate. However, the reductionism of the RDoC systemmakes it an
important methodological tool. The RDoC system offers a good
platform for the integral study of clinical data and for the critical
evaluation of existing animal models based on systematic exami-
nation of endophenotypes.
To summarise our analysis of the RDoC system, we may
conclude that:
1. The RDoC system implies the same mechanisms underlie
normal and dysfunctional brain function. The RDoc system also
suggests the existence of a psychopathological continuum.
Fig. 3. The “interacting domains” approach. The RDoC paradigm provides the opportunity to create a theoretical framework to decipher interactions between behavioural
domains. For instance, the simplest interaction model might comprise 3 domains. Considering a possible hierarchy between domains, it can be predicted that only some in-
tegrations will serve healthy brain activity. Thus, negative and positive affect transition is subject to regulation by the cognitive systems domain. Pathology appears as a mani-
festation of aberrant crosstalk and disturbed hierarchy among the systems. Thus, prevalence of either positive or negative affects feeds back on the cognitive systems.
E. Anderzhanova et al. / Neurobiology of Stress 7 (2017) 47e56 532. In the present state, the RDoC system does not consider
dynamical and developmental aspects of a disease, psychoso-
matic co-morbidities, paradigms of therapeutic interventions
nor interactions between domain and components of Units of
Analysis.
3. Four of the 5 RDoC domains correspond to The Affective
Neuroscience Scale. A homology of the affective systems in
humans and animals supports experimental models of the
emotion and defence response dysfunction. However, the high
translational value of these models is limited by the dissimi-
larities between developmental programs and psycho-social
contexts of human disorders.
4. Nonetheless, the RDoC system offers a valid and instructive
framework for basic research allowing one to focus on domains
and their constructs and to explore endophenotype-based
models. This avoids a major challenge of translational studies,
which assume a strict disease-to-model correspondence.Declaration of conﬂicting interests
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